First patient dosed in Phase 3 LUTEON[1] trial evaluating TLX250-Tx in relapsed or recurrent clear cell renal cell carcinoma (ccRCC).
Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory diseases, today announced the first patient has been dosed in its Phase 2b ...
Cassidy Lockwood exemplifies dedication and expertise as an oncology nurse, consistently practicing evidence-based medicine and prioritizing patient-centered care. Her teamwork, communication skills, ...
WASHINGTON, June 1, 2026 /PRNewswire/ -- The Patient First Coalition (PFC), a national coalition of more than 1,100 Ambassadors representing over 50 organizations committed to putting patients first, ...
A new paper describes how, despite widespread enthusiasm about artificial intelligence's potential to revolutionize healthcare and the use of AI-powered tools on millions of patients already, no ...
Hospitals and health systems have been discussing digital-first patient engagement for a while now, but fewer organizations than you might think have made huge strides forward on that front. Likewise, ...
CLOSE OUT THE WEEK. THANKS, DALENCIA. WELL, IN THIS MORNING’S MEDICAL ALERT, FLU CASES ARE SPIKING ACROSS THE COUNTRY, INCLUDING HERE IN MARYLAND. BUT WHAT CAN YOU DO TO STAY HEALTHY THIS SEASON?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results